Cytokines are key factors in this condition; several proinflammatory cytokines, including IL-4, IL-6 and IL-17, serve as markers of chronic GvHD, and many current treatments for GvHD involve targeting cytokines31. This evidence concerns the gene IL4 and chronic graft versus host disease.